A study at University of Colorado's Gates Institute on the Anschutz Medical Campus is looking at CAR-T in adult patients with acute lymphocytic leukemia...
When a cancer therapy is new and carries unknown risks, typically the first patients who receive it are those who are out of other options, Fry said...
[
add
]
[
|
|
...
]